CHIAPPALUPI, SARA
 Distribuzione geografica
Continente #
NA - Nord America 1.193
EU - Europa 848
AS - Asia 474
SA - Sud America 18
OC - Oceania 6
AF - Africa 4
Continente sconosciuto - Info sul continente non disponibili 2
Totale 2.545
Nazione #
US - Stati Uniti d'America 1.174
IT - Italia 332
SG - Singapore 235
IE - Irlanda 201
HK - Hong Kong 76
CN - Cina 69
SE - Svezia 53
DE - Germania 38
RO - Romania 35
UA - Ucraina 27
AT - Austria 26
KR - Corea 26
RU - Federazione Russa 26
FI - Finlandia 21
FR - Francia 21
GB - Regno Unito 19
BR - Brasile 16
PH - Filippine 16
BE - Belgio 14
CA - Canada 10
IN - India 9
MX - Messico 9
NL - Olanda 9
CH - Svizzera 8
TR - Turchia 8
PL - Polonia 6
VN - Vietnam 6
AU - Australia 5
JP - Giappone 5
LB - Libano 5
TW - Taiwan 4
EG - Egitto 3
ES - Italia 3
GR - Grecia 3
UZ - Uzbekistan 3
AE - Emirati Arabi Uniti 2
CZ - Repubblica Ceca 2
EU - Europa 2
IQ - Iraq 2
IR - Iran 2
MD - Moldavia 2
MY - Malesia 2
PK - Pakistan 2
CL - Cile 1
CO - Colombia 1
DK - Danimarca 1
IL - Israele 1
KH - Cambogia 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
TN - Tunisia 1
Totale 2.545
Città #
Chandler 253
Dublin 198
Singapore 186
Perugia 139
San Mateo 89
Hong Kong 74
Santa Clara 70
Boardman 69
Dearborn 44
Redmond 44
Medford 41
Altamura 40
Ann Arbor 40
Princeton 40
Wilmington 38
Bucharest 33
Andover 26
Beijing 24
Vienna 24
Lawrence 23
Ashburn 22
Falls Church 19
Brussels 14
Norwalk 12
Cebu City 11
Los Angeles 10
Saint Petersburg 10
Parma 9
Redwood City 9
Tijuana 8
Jacksonville 7
Seoul 7
Collazzone 6
Des Moines 6
Glasgow 6
New York 6
Trinity 6
Bologna 5
Dong Ket 5
Helsinki 5
Woodbridge 5
Dumaguete 4
Falkenstein 4
Fremont 4
Konya 4
Kunming 4
Milan 4
Ottawa 4
Phoenix 4
Simi Valley 4
Xiamen 4
Amsterdam 3
Bristol 3
Cairo 3
Cambridge 3
Delft 3
Frankfurt Am Main 3
Hachenburg 3
Houston 3
Istanbul 3
Macerata 3
Moscow 3
Mumbai 3
Perth 3
Rimini 3
São Paulo 3
Villeurbanne 3
Barrie 2
Bengaluru 2
Chicago 2
Chisinau 2
Cyberjaya 2
Dallas 2
Didcot 2
Dongjak-gu 2
Florence 2
Guangzhou 2
Hebei 2
Jeju City 2
Jinan 2
Karaj 2
Kinross 2
Lugano 2
Mainz 2
Modena 2
Monreale 2
Montreal 2
Nanjing 2
Nürnberg 2
Olomouc 2
Oneonta 2
Salvador 2
Seongnam-si 2
Sindelfingen 2
Suwon 2
Taipei 2
Turin 2
Valenciennes 2
Victoria 2
Wollongong 2
Totale 1.837
Nome #
Intraperitoneal injection of microencapsulated Sertoli cells restores muscle morphology and performance in dystrophic mice 119
RAGE in the pathophysiology of skeletal muscle. 101
IDO1 suppresses inhibitor development in hemophilia A treated with factor VIII 95
Histological muscle characterization in hypertrophied Marchigiana cattle breed 94
Generation of an mdx/Ager–/– double mutant mouse. Preliminary data on skeletal muscle architecture. 91
Sertoli cells protect C2C12 myotubes against atrophy and induce utrophin expression in canine and human dystrophic myotubes. 89
Targeting RAGE as a potential therapeutic approach to Duchenne muscular dystrophy 78
Toward the identification of receptor for advanced glycation end-products (RAGE) as a muscle biomarker of cancer cachexia. 76
S100B protein regulates myoblast and macrophage functions in skeletal muscle regeneration 76
RAGE and its ligands, S100B and HMGB1, are molecular determinants of cancer-induced muscle wasting. 72
Transplantation of microencapsulated Sertoli cells: a new potential antiinflammatory approach to Duchenne muscular dystrophy (DMD). 70
Natural products to counteract muscle atrophy 69
Transplantation of microencapsulated Sertoli cells in mdx mice reduces muscle inflammation and promotes muscle regeneration 68
Effects of intraperitoneal injection of microencapsulated Sertoli cells on chronic and presymptomatic dystrophic mice 67
Targeting RAGE prevents muscle wasting and prolongs survival in cancer cachexia 65
Sertoli cell-secreted factors have promyogenic and antifibrotic properties on human DMD myoblasts with different mutations. 65
Employment of Microencapsulated Sertoli Cells as a New Tool to Treat Duchenne Muscular Dystrophy 64
Microencapsulated Sertoli cells sustain myoblast proliferation without affecting the myogenic potential. In vitro data 61
Levels of S100B protein drive the reparative process in acute muscle injury and muscular dystrophy 59
The effects of microgravity on human skeletal muscle regeneration. 59
The receptor RAGE: a potential molecular target in cancer cachexia 58
Mdx/Ager–/– mice show reduced muscle necrosis and inflammation compared with mdx mice 57
Do porcine Sertoli cells represent an opportunity for Duchenne muscular dystrophy? 57
Use of Sertoli cells to treat DMD patients is supported by their immunomodulatory rather than immunosuppressive effect 56
Absence of RAGE in an animal experimental model of Duchenne muscular dystrophy results in reduced muscle necrosis and inflammation 53
HEREGULIN-INDUCED UTROPHIN UPREGULATION PROMOTES RECOVERY OF MUSCLE HOMEOSTASIS IN MDX MICE TRANSPLANTED WITH MICROENAPSULATED SERTOLI CELLS 49
Novel data support the use of microencapsulated Sertoli cells as a potential treatment of DMD patients. 48
Transplantation of microencapsulated Sertoli cells in a mouse model of Duchenne muscular dystrophy (DMD) reduces inflammation and rescues muscle performance. 46
Defective RAGE activity in embryonal rhabdomyosarcoma cells results in high PAX7 levels that sustain migration and invasiveness 46
The novel DMD experimental model, mdx/Ager–/– mouse reveals a role of RAGE in inflammatory processes in dystrophic muscles. 45
Hyperactivated rage in comorbidities as a risk factor for severe covid-19—the role of rage-ras crosstalk 45
Receptor for advanced glycation end-products (RAGE) as a biomarker of muscle wasting in cancer conditions 44
S100 proteins in obesity: liaisons dangereuses 43
Involvement of a RAGE/p38MAPK/myogenin axis in cancer cachexia. 43
Reductive stress in striated muscle cells 41
RAGE expression in rhabdomyosarcoma cells modulates metastasis formation in vivo. 39
Identification of Withania somnifera-Silybum marianum-Trigonella foenum-graecum Formulation as a Nutritional Supplement to Contrast Muscle Atrophy and Sarcopenia 39
Intraperitoneal transplantation of microencapsulated Sertoli cells counteracts muscle inflammation and rescues muscle performance in mdx mice. 37
Beneficial effects of horsetail (Equisetum arvense) in experimental models of sarcopenia and osteoporosis 36
Targeting RAGE to prevent SARS-CoV-2-mediated multiple organ failure: Hypotheses and perspectives 32
KYMASIN UP Natural Product Inhibits Osteoclastogenesis and Improves Osteoblast Activity by Modulating Src and p38 MAPK 31
Equisetum arvense standardized extract hinders age-related sarcopenia 31
Pharmacological targeting of the receptor for advanced glycation end-products (RAGE) to counteract cancer cachexia 27
Sertoli cells improve myogenic differentiation, reduce fibrogenic markers, and induce utrophin expression in human dmd myoblasts 25
Identification of natural products able to counteract the formation of advanced glycation end-products (AGEs) sustaining muscle atrophy 25
Ablation of RAGE (receptor for advanced glycation end-products) translates into reduced tumorigenic and cachectic potential in LLC-tumor bearing mice 24
Equisetum arvense standardized dried extract hinders age-related osteosarcopenia. 16
Sertoli cells induce utrophin expression in human DMD myotubes with different mutations and exert promyogenic and antifibrotic effects 15
Preparation of Human Muscle Precursor Cells for the MyoGravity Project - Cell Culture in Experiment Units for Space Flight Purpose 14
Beneficial effects of horsetail (Equisetum arvense) in in vitro models of sarcopenia and osteoporosis 12
Self-powered temperature sensors harnessing membrane potential of living cells 11
Sertoli cells have promyogenic and antifibrotic effects, and induce utrophin expression in human DMD myotubes with different mutations in a heregulin β1/ErbB2/ERK1/2-dependent manner 9
Grafted Sertoli Cells Exert Immunomodulatory Non-Immunosuppressive Effects in Preclinical Models of Infection and Cancer 9
The MyoGravity project to study real microgravity effects on human muscle precursor cells and tissue 2
Totale 2.703
Categoria #
all - tutte 11.428
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 11.428


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020177 0 0 0 0 14 34 35 9 67 15 2 1
2020/2021249 1 7 12 6 108 31 34 4 21 11 7 7
2021/2022420 4 65 9 19 12 12 12 106 12 39 58 72
2022/2023717 43 128 5 64 60 77 1 34 269 2 27 7
2023/2024387 18 28 9 35 18 12 102 8 19 24 37 77
2024/2025531 46 103 148 84 150 0 0 0 0 0 0 0
Totale 2.703